'Developing a new drug is stumbling in the dark without a map. We are building the GPS'
When Immunai, a machine learning firm creating a ‘GPS’ for drug development, was just getting started a leading professor was skeptical about it – now he's their close consultant
Site référencé:
Haaretz
Haaretz
Three months ago Putin tried to turn the clocks back 30 years. He failed
25/05/2022
This is the Mossad’s bold new Iran policy
25/05/2022
Prospects for reviving Iran nuclear deal 'tenuous' at best, U.S. envoy says
25/05/2022
Why Israel’s 'hasbara queen' failed miserably to explain Shireen Abu Akleh’s killing
25/05/2022
One of the greatest Russian photojournalists moved to Israel : 'I'll never photograph wars again'
25/05/2022
Renewed Iran nuclear deal is in Israel's best interest, former intel chief says
25/05/2022